Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the ...
The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...
A new class of engineered extracellular vesicles induces antigen-specific regulatory T cells, offering a targeted strategy ...
News-Medical.Net on MSN
Engineered extracellular vesicles enable antigen-specific regulatory T cell induction
A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has ...
A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has ...
Explore how engineered extracellular vesicles can enhance antigen-specific regulatory T cells to improve immune response.
The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea ...
This important study provides a detailed analysis of the transcriptional landscape of the mouse hippocampus in the context of various physiological states. The main conclusions have solid support: ...
LBL-047 (DNTH212) is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, ...
Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive effect against a ...
Japanese shipbuilder Mitsubishi Heavy Industries (MHI) launched the 12th and final Mogami-class multirole frigate for the ...
A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback